PE52599A1 - Vacuna viva recombinante aviaria, que comprende como vector el virus de la laringotraqueitis infecciosa - Google Patents
Vacuna viva recombinante aviaria, que comprende como vector el virus de la laringotraqueitis infecciosaInfo
- Publication number
- PE52599A1 PE52599A1 PE1997000548A PE00054897A PE52599A1 PE 52599 A1 PE52599 A1 PE 52599A1 PE 1997000548 A PE1997000548 A PE 1997000548A PE 00054897 A PE00054897 A PE 00054897A PE 52599 A1 PE52599 A1 PE 52599A1
- Authority
- PE
- Peru
- Prior art keywords
- promoter
- virus
- vector
- proteins
- cmvie
- Prior art date
Links
- 108010008038 Synthetic Vaccines Proteins 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002458 infectious effect Effects 0.000 title 1
- 229940124551 recombinant vaccine Drugs 0.000 title 1
- 239000013612 plasmid Substances 0.000 abstract 3
- 241000711404 Avian avulavirus 1 Species 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 241000711450 Infectious bronchitis virus Species 0.000 abstract 1
- 241000702626 Infectious bursal disease virus Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16041—Use of virus, viral particle or viral elements as a vector
- C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9608243A FR2750866B1 (fr) | 1996-06-27 | 1996-06-27 | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE52599A1 true PE52599A1 (es) | 1999-07-16 |
Family
ID=9493649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997000548A PE52599A1 (es) | 1996-06-27 | 1997-06-27 | Vacuna viva recombinante aviaria, que comprende como vector el virus de la laringotraqueitis infecciosa |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6153199A (enExample) |
| EP (1) | EP0914458A1 (enExample) |
| JP (1) | JP2000512844A (enExample) |
| AR (1) | AR008620A1 (enExample) |
| AU (1) | AU739374B2 (enExample) |
| CO (1) | CO4700303A1 (enExample) |
| FR (1) | FR2750866B1 (enExample) |
| ID (1) | ID18351A (enExample) |
| MA (1) | MA24222A1 (enExample) |
| PE (1) | PE52599A1 (enExample) |
| TN (1) | TNSN97109A1 (enExample) |
| WO (1) | WO1997049826A1 (enExample) |
| ZA (1) | ZA975618B (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6913751B2 (en) | 1992-06-12 | 2005-07-05 | Schering-Plough Veterinary Corporation | Recombinant avian herpesvirus useful in vaccine production |
| US6632664B1 (en) | 1997-10-03 | 2003-10-14 | Nippon Zeon Co., Ltd. | Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
| AR031405A1 (es) * | 2000-11-21 | 2003-09-24 | Wyeth Corp | Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo |
| JP2002356441A (ja) * | 2001-03-15 | 2002-12-13 | Akzo Nobel Nv | 組換え伝染性喉頭気管炎ウイルスワクチン |
| US7314715B2 (en) * | 2001-06-14 | 2008-01-01 | Schering-Plough Animal Health Corporation | Recombinant avian herpesvirus useful in vaccine production |
| EP2022799A2 (en) | 2001-11-16 | 2009-02-11 | Biogen Idec Inc. | Polycistronic expression of antibodies |
| US20030157641A1 (en) * | 2001-11-16 | 2003-08-21 | Idec Pharmaceuticals Corporation | Polycistronic expression of antibodies |
| EP1606419A1 (en) | 2003-03-18 | 2005-12-21 | Quantum Genetics Ireland Limited | Systems and methods for improving protein and milk production of dairy herds |
| US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
| MXPA06005424A (es) | 2003-11-13 | 2007-01-25 | Univ Georgia Res Found | Metodos para caracterizar virus de enfermedad bursal infecciosa. |
| ATE510928T1 (de) | 2004-02-19 | 2011-06-15 | Univ Alberta | Leptinpromotor-polymorphismen und verwendungen davon |
| HRP20100314T1 (hr) | 2005-04-25 | 2010-08-31 | Merial Ltd. | Cjepivo protiv nipah virusa |
| US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
| US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
| EP1951751B1 (en) | 2005-11-14 | 2017-11-01 | Merial, Inc. | Gene therapy for renal failure |
| US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
| WO2010115133A2 (en) | 2009-04-03 | 2010-10-07 | Merial Limited | Newcastle disease virus vectored avian vaccines |
| EP2327764B1 (en) | 2009-11-30 | 2011-12-28 | United Cancer Research Institute | New clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer |
| US10633667B2 (en) | 2009-12-28 | 2020-04-28 | Boehringer Ingelheim Animal Health USA Inc. | Recombinant NDV antigen and uses thereof |
| BR112013002525A2 (pt) * | 2010-08-02 | 2016-05-31 | Univ Georgia | vírus da laringotraqueíte infecciosa (iltv) modificado e usos do mesmo |
| CN103269714B (zh) | 2010-08-31 | 2016-06-29 | 梅里亚有限公司 | 以新城疫病毒为载体的疱疹病毒疫苗 |
| WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
| US20140287931A1 (en) | 2011-04-04 | 2014-09-25 | Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis | Methods and compositions for predicting resistance to anticancer treatment |
| EP2694677A2 (en) | 2011-04-04 | 2014-02-12 | Netherland Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
| AU2012245395A1 (en) | 2011-04-20 | 2013-11-14 | Merial, Inc. | Adjuvanted rabies vaccine with improved viscosity profile |
| JP6407714B2 (ja) | 2011-04-25 | 2018-10-17 | アドヴァンスド バイオサイエンス ラボラトリーズ インコーポレイテッド | 短縮型ｈｉｖエンベロープタンパク質（ｅｎｖ）、前記に関連する方法及び組成物 |
| US9669085B2 (en) | 2011-06-01 | 2017-06-06 | Merial Inc. | Needle-free administration of PRRSV vaccines |
| ES2626297T3 (es) | 2011-08-12 | 2017-07-24 | Merial, Inc. | Preservación asistida por vacío de productos biológicos, en particular de vacunas |
| WO2013093629A2 (en) | 2011-12-20 | 2013-06-27 | Netherlands Cancer Institute | Modular vaccines, methods and compositions related thereto |
| WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
| WO2014081958A1 (en) | 2012-11-21 | 2014-05-30 | Cardiomems, Inc. | Devices, systems, and methods for pulmonary arterial hypertension (pah) assessment and treatment |
| US9556419B2 (en) | 2013-03-12 | 2017-01-31 | Merial Inc. | Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof |
| WO2014145712A1 (en) | 2013-03-15 | 2014-09-18 | Cardiomems, Inc. | Methods for the treatment of cardiovascular conditions |
| EP2845904A1 (en) * | 2013-09-06 | 2015-03-11 | Ceva Sante Animale | Recombinant Marek's disease viruses and uses thereof |
| US10010499B2 (en) | 2014-11-03 | 2018-07-03 | Merial Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
| DK3313864T3 (da) | 2015-06-23 | 2021-11-01 | Boehringer Ingelheim Animal Health Usa Inc | Rekombinante virusvektorer indeholdende prrsv minor protein og fremgangsmåder til fremstilling og anvendelse deraf |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990002802A2 (en) * | 1988-09-13 | 1990-03-22 | Institute For Animal Health Limited | Viral nucleotide sequences |
| WO1992003554A1 (en) * | 1990-08-24 | 1992-03-05 | Arthur Webster Pty. Ltd. | Infectious laryngotracheitis virus vaccine |
| WO1993025655A1 (en) * | 1992-06-12 | 1993-12-23 | Genencor International, Inc. | Enzymatic compositions and methods for producing stonewashed look on indigo-dyed denim fabric |
| WO1996000791A1 (en) * | 1994-06-30 | 1996-01-11 | The Board Of Trustees Of The University Of Illinois | Recombinant infectious laryngotracheitis virus and vaccine |
| FR2728794B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro |
| JP3964458B2 (ja) * | 1995-03-23 | 2007-08-22 | シェリング−プロウ・リミテッド | 組換え型伝染性喉頭気管炎ウイルスおよびその使用 |
-
1996
- 1996-06-27 FR FR9608243A patent/FR2750866B1/fr not_active Expired - Lifetime
-
1997
- 1997-06-23 MA MA24675A patent/MA24222A1/fr unknown
- 1997-06-25 JP JP10502456A patent/JP2000512844A/ja active Pending
- 1997-06-25 TN TNTNSN97109A patent/TNSN97109A1/fr unknown
- 1997-06-25 WO PCT/FR1997/001138 patent/WO1997049826A1/fr not_active Ceased
- 1997-06-25 AU AU34487/97A patent/AU739374B2/en not_active Expired
- 1997-06-25 EP EP97930591A patent/EP0914458A1/fr not_active Withdrawn
- 1997-06-25 AR ARP970102799A patent/AR008620A1/es unknown
- 1997-06-25 ZA ZA975618A patent/ZA975618B/xx unknown
- 1997-06-26 ID IDP972222A patent/ID18351A/id unknown
- 1997-06-27 CO CO97036155A patent/CO4700303A1/es unknown
- 1997-06-27 PE PE1997000548A patent/PE52599A1/es not_active Application Discontinuation
-
1998
- 1998-12-23 US US09/219,932 patent/US6153199A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CO4700303A1 (es) | 1998-12-29 |
| FR2750866A1 (fr) | 1998-01-16 |
| WO1997049826A1 (fr) | 1997-12-31 |
| AU3448797A (en) | 1998-01-14 |
| AR008620A1 (es) | 2000-02-09 |
| AU739374B2 (en) | 2001-10-11 |
| ID18351A (id) | 1998-04-02 |
| EP0914458A1 (fr) | 1999-05-12 |
| TNSN97109A1 (fr) | 2005-03-15 |
| JP2000512844A (ja) | 2000-10-03 |
| FR2750866B1 (fr) | 1998-11-27 |
| US6153199A (en) | 2000-11-28 |
| MA24222A1 (fr) | 1997-12-31 |
| ZA975618B (en) | 1998-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE52599A1 (es) | Vacuna viva recombinante aviaria, que comprende como vector el virus de la laringotraqueitis infecciosa | |
| Bayliss et al. | A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus | |
| US5182210A (en) | Fowlpox virus promoters | |
| CA2196570C (en) | Recombinant herpesvirus of turkeys and uses thereof | |
| US5223424A (en) | Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence | |
| EP0431668B1 (en) | Recombinant herpesvirus of turkeys and live vector vaccines derived thereof | |
| Fodor et al. | Induction of protective immunity in chickens immunised with plasmid DNA encoding infectious bursal disease virus antigens | |
| AU734085B2 (en) | Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus. | |
| AR013063A1 (es) | Formula de vacuna aviaria, su utilizacion y kit de vacunacion | |
| AU711813B2 (en) | Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease | |
| AU670538B2 (en) | Infectious bursal disease virus recombinant poxvirus vaccine | |
| CA2283093A1 (en) | Recombinant chimeric viruses and uses thereof | |
| US12491242B2 (en) | Recombinant viruses and the uses thereof | |
| DE68912478D1 (de) | Rekombinantes Marek-Krankheitsvirus, Verfahren zu seiner Herstellung, und Vakzine. | |
| US5641490A (en) | Infectious bursal disease virus recombinant poxvirus vaccine | |
| US5374558A (en) | Fowlpox virus promoter | |
| US5658572A (en) | Infectious bursal disease virus recombinant poxvirus vaccine | |
| US6136318A (en) | Recombinant fowlpox viruses and uses thereof | |
| US5925358A (en) | Recombinant fowlpox viruses and uses thereof | |
| AU750084B2 (en) | Recombinant herpesvirus of turkeys and uses thereof II | |
| RU99103126A (ru) | Формула полинуклеотидной вакцины для птиц | |
| ECSP972164A (es) | Vacunas de uso aviario a base de virus de laringotraqueitis infecciosa | |
| DK175980B1 (da) | Recombinante vacciniavira og anvendelsen af samme | |
| RU2019101007A (ru) | Рекомбинантные непатогенные конструкции вируса болезни марека, кодирующие антигены вируса инфекционного ларинготрахеита и вируса инфекционного бурсита | |
| AU7215900A (en) | Recombinant fowlpox viruses and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |